News | October 17, 2011

CDC Reports Uneven Declines in Coronary Heart Disease by State and Race/Ethnicity


October 17, 2011 – The number of Americans who report they have coronary heart disease – which includes heart attack and angina (chest pain) – continues to decline but rates vary widely from state to state and by race and ethnicity, according to a new report published today in the Morbidity and Mortality Weekly Report of the Centers for Disease Control and Prevention (CDC).

From 2006 to 2010, the number of people in the United States who report they have been told by a health professional they have coronary heart disease declined overall from 6.7 percent to 6 percent. The data came from CDC?s Behavioral Risk Factor Surveillance System (BRFSS), a phone survey conducted each year of adults aged 18 and older.

The report attributes the decline to a combination of reductions in prevalence of high-risk populations for heart disease such as smokers, patients with uncontrolled high blood pressure, and uncontrolled high blood cholesterol along with improvements in treatments for heart disease.

Despite that decline, cardiovascular disease remains the leading cause of death in the United States killing roughly the same number of Americans each year as cancer, lower respiratory diseases (including pneumonia) and accidents combined.

The highest rates of self–reported coronary heart disease are among older adults aged 65 and older (19.8 percent) and American Indians/Alaskan Natives (11.6 percent).

The report also notes geographic differences in self–reported coronary heart disease. In 2010, coronary heart disease prevalence ranged from lows of 3.7 percent in Hawaii and 3.8 percent in the District of Columbia to highs of 8 percent in West Virginia and 8.2 percent in Kentucky. Generally, populations in Southern states reported the highest levels of coronary heart disease.

“Where you live and how you live matters to your heart,” said CDC Director Thomas R. Frieden, M.D., M.P.H . “The Million Hearts national initiative, which can prevent 1 million heart attacks and strokes over the next five years, focuses on actions people can take themselves and actions that businesses, communities and health providers can take to prevent heart attacks and strokes today.”

Million Hearts seeks to improve clinical care by helping patients learn and follow their ABCS:

  • Aspirin for people at risk
  • Blood pressure control
  • Cholesterol management
  • Smoking cessation

Fewer than half of Americans who should be taking an aspirin a day are taking one; fewer than half of Americans with high blood pressure have it under control.  Only 1 in 3 Americans with high cholesterol is effectively treated, and less than a quarter of Americans who smoke get help to quit when they see their doctor.

 “We're all at risk for heart disease and stroke,” said Jing Fang, M.D., epidemiologist with CDC?s Division of Heart Disease and Stroke Prevention. “People of all ages, genders, races, and ethnicities are affected. However, certain groups, including American Indians/Alaskan Natives, African-Americans and older adults, are at higher risk than others.”

The MMWR report on state coronary heart disease prevalence is available at www.cdc.gov/mmwr

 


Related Content

News | Cardiovascular Clinical Studies

Aug. 15, 2024 — According to a new study being presented at ACC Asia 2024 in Delhi, India, drinking over 400 mg of ...

Home August 14, 2024
Home
Videos | Cardiovascular Clinical Studies

As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits ...

Home July 30, 2024
Home
News | Cardiovascular Clinical Studies

July 25, 2024 — BioCardia, Inc., a global leader in cellular and cell-derived therapeutics for the treatment of ...

Home July 25, 2024
Home
News | Cardiovascular Clinical Studies

July 18, 2024 — Elucid, a pioneering AI medical technology company providing physicians with imaging analysis software ...

Home July 18, 2024
Home
News | Cardiovascular Clinical Studies

July 10, 2024 — CellProthera, a private company specializing in cell-based therapies for repairing ischemic tissues, and ...

Home July 10, 2024
Home
News | Cardiovascular Clinical Studies

July 9, 2024 — Microbot Medical Inc. announced the completion of the first procedure in a patient utilizing its LIBERTY ...

Home July 09, 2024
Home
News | Cardiovascular Clinical Studies

June 26, 2024 — Semaglutide, a medication initially developed for type 2 diabetes and obesity, significantly improves ...

Home June 26, 2024
Home
News | Cardiovascular Clinical Studies

June 21, 2024 — Lexicon Pharmaceuticals, Inc. announced that the peer-reviewed Journal of the American College of ...

Home June 21, 2024
Home
News | Cardiovascular Clinical Studies

June 20, 2024 — Microbot Medical Inc. announced its agreement with Brigham and Women’s Hospital (BWH), a leading ...

Home June 20, 2024
Home
News | Cardiovascular Clinical Studies

June 20, 2024 — A programming algorithm, being tested by HonorHealth Research Institute for those patients with new or ...

Home June 20, 2024
Home
Subscribe Now